Clinical Trial Detail

NCT ID NCT03732950
Title Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.